Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
Federal funding opportunity RFA-CA-27-002 from National Institutes of Health (Department of Health and Human Services).
Apply on Grants.gov →Application closes November 10, 2026
- Posted
- June 3, 2026
- Closes
- November 10, 2026
- Award ceiling
- $300,000
- Program funding
- $5,900,000
- Expected awards
- 13
- Cost sharing
- No
- Instrument
- Grant
- Assistance listing
- 93.394
- Category
- Health
- Archives
- January 9, 2027
Program funding history
Awards made under Assistance Listing 93.394 across FY2024–FY2026, from public federal spending records.
- FY2024 obligated
- $533.3M
- FY2025 obligated
- $595.6M
- FY2026 (to date) obligated
- $227.4M
- Awards in window
- 2,123
Top recipients: Regents of the University of California, San Francisco, the, Fred Hutchinson Cancer Center, The Johns Hopkins University, The Leland Stanford Junior University, Sloan-kettering Institute for Cancer Research
Source: USAspending.gov · refreshed July 2026
Synopsis
Who can apply
- State governments
- Native American tribal organizations (other than Federally recognized tribal governments)
- Independent school districts
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- For profit organizations other than small businesses
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Special district governments
- County governments
- Private institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Small businesses
- Public housing authorities/Indian housing authorities
- City or township governments
Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
How to apply
Applications go through the official government listing. Grants Radar links you straight to the source.
Get grants like this every Tuesday — free
One email a week: the biggest new federal grants and what’s closing soon. Unsubscribe in one click.
Similar grants
- Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 Clinical Trial Required)
- Data Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (Collaborative U24 Clinical Trial Required)
- Investigator Initiated Clinical Trials of Complementary and Integrative Interventions Delivered Remotely or via mHealth (R01 Clinical Trial Required)
- Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science Award (CTSA) Program (R03 Clinical Trial Optional)
- Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)
- Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)
Never miss a funding deadline again
Grants Radar sends AI-enriched alerts on federal grants and contracts matched to what you do. Founding seats are limited and locked for life.
Get funding alerts